ProjectGMMG-HD6 – A randomized phase III trial on the effect of elotuzumab in VRD inuction / consolidation and…
Basic data
Acronym:
GMMG-HD6
Title:
A randomized phase III trial on the effect of elotuzumab in VRD inuction / consolidation and lenalidomide maintainance in patients with newly diagnosed myeloma
Duration:
07/07/2015 to 31/10/2021
Abstract / short description:
A randomized phase III trial on the effect of elotuzumab in VRD inuction / consolidation and lenalidomide maintainance in patients with newly diagnosed myeloma
Keywords:
Multiples Myelom
Elotuzumab
Lenalidomide
Involved staff
Managers
Weisel, Katja
Faculty of Medicine
University of Tübingen
University of Tübingen
Local organizational units
Internal Medicine Department II
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Heidelberg, Baden-Württemberg, Germany
Heidelberg, Baden-Württemberg, Germany